Jennifer Gori, PhD

Obsidian Therapeutics, Inc., Associate Director and Head of Immuno-oncology and Pharmacology


What is your current professional status?

Associate Director and Head of Immuno-oncology and Pharmacology

What is your work setting?

Biotechnology Company

What is your scientific area of research?

Genetically Engineered Cell Therapy

Why do you want to be a mentor?

I like to instill confidence and enthusiasm for scientific discovery in my peers and in junior scientists. I also hope to empower them to clarify their goals, and provide support when needed to help then confidently and strategically pursue these goals.

As a mentor, what are you hoping to gain from this experience?

I hope to provide perspective on how one can shape their own career path. There are many exciting opportunities in different types of organizations, with varied responsibilities and scientific disciplines to be learned, harnessed, and applied to the clinic. As someone who has held different positions in both academic and industrial settings, I've learned how to merge my interests and expertise with jobs and work environments that are mutually beneficial to myself and the organization, in a shared goal to develop new therapies for patients.

Summarize in a brief paragraph (150 words or less), please provide a biography that describes who you are and what you do in the field of gene and/or cell therapy:

  • Compatibility of Scientific Specialties: 3
  • Geographic Location: 4
  • Professional Status / Success: 5 (least)
  • Compatibility of Career Path: 1 (most)
  • Communication Style: 2

Summarize in a brief paragraph (150 words or less), please provide a biography that describes who you are and what you do in the field of gene and/or cell therapy:

Jennifer Gori is currently Associate Director and Head of Immuno-oncology and Pharmacology at Obsidian Therapeutics, a biotechnology company building cell therapies with pharmacologic systems for precise and dynamic control of engineered cells. In 2014, she was one of the first research scientists at Editas Medicine, leading a team on the development of CRISPR nuclease-mediated hematopoietic stem cell therapies for Sickle Cell Disease and immunodeficiencies.

Dr. Gori has >13 years of experience in stem cell and T cell gene editing and gene therapy, engineering blood cells from pluripotent stem cells, and transplantation immunology. Prior to Editas, Dr. Gori was Associate in Clinical Research at Fred Hutchinson Cancer Research Center, where she focused on translational engineered stem cell and T cell therapies. Dr. Gori received her PhD in Microbiology, Immunology, and Cancer Biology in 2008 from the University of Minnesota where she studied lentiviral gene therapy in hematopoietic stem cells and hematopoiesis.

View CV

2019
22nd Annual Meeting
April 29 – May 2 | Washington D.C.
Close